Form 4: Haemonetics EVP, Chief Technology Officer Anila Lingamneni Reports Share Transactions

Anila Lingamneni, EVP and Chief Technology Officer of Haemonetics, reports acquisition of shares from a performance share unit award and disposition of shares for tax obligations.

Summary

• Anila Lingamneni, the EVP and Chief Technology Officer of Haemonetics Corp, filed a Form 4 detailing changes in beneficial ownership.
• On May 28, 2024, Lingamneni acquired 14,140 shares of common stock from a performance share unit (PSU) award granted on May 18, 2021.
• These shares were earned based on Haemonetics' total shareholder return relative to the S&P MidCap 400 Index from May 18, 2021, to May 17, 2024.
• The Compensation Committee of the Board of Directors certified the performance on May 26, 2024.
• Also on May 28, 2024, Lingamneni disposed of 5,279 shares at a price of $95.73 to cover tax obligations related to the vesting of the PSUs.
• Following these transactions, Lingamneni beneficially owns 23,546 shares of Haemonetics Corp, which includes unvested restricted stock units (RSUs).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to equity compensation. The vesting of PSUs is a positive sign, but the sale of shares to cover taxes is a normal occurrence.

Positives

• The vesting of performance share units indicates that Haemonetics met certain performance criteria related to shareholder return compared to the S&P MidCap 400 Index.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The vesting of PSUs suggests the company is meeting its performance goals as set by the board.

Comparison to Industry Standards

• Performance-based equity compensation, such as PSUs, is a common practice among publicly traded companies, particularly those in the S&P MidCap 400, to align management's interests with those of shareholders.
• The specific performance metrics, such as total shareholder return relative to an index, are tailored to the company's strategic goals and industry benchmarks.
• Companies like Medtronic and Baxter International also utilize similar performance-based compensation plans to incentivize executives.

Stakeholder Impact

• The vesting of PSUs can be viewed positively by shareholders as it indicates the company has met certain performance targets.
• The transactions themselves have a minimal direct impact on other stakeholders.

Key Dates